Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up.
Paoletti G, Gomez-Lara J, Brugaletta S, Ñato M, Romaguera R, Roura G, Ferreiro JL, Teruel L, Gracida M, Ortega-Paz L, Gomez-Hospital JA, Sabaté M, Cequier À. Paoletti G, et al. EuroIntervention. 2018 Jun 20;14(2):206-214. doi: 10.4244/EIJ-D-17-00255. EuroIntervention. 2018. PMID: 28943494 Free article.
Pre-eclampsia/eclampsia and hepatic rupture.
Vigil-De Gracia P, Ortega-Paz L. Vigil-De Gracia P, et al. Int J Gynaecol Obstet. 2012 Sep;118(3):186-9. doi: 10.1016/j.ijgo.2012.03.042. Epub 2012 Jun 19. Int J Gynaecol Obstet. 2012. PMID: 22717416 Review.
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis.
Galli M, Occhipinti G, Benenati S, Laborante R, Ortega-Paz L, Franchi F, D'Amario D, Nerla R, Castriota F, Frati G, Biondi-Zoccai G, Sciarretta S, Angiolillo DJ. Galli M, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):526-536. doi: 10.1093/ehjcvp/pvae036. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38754988
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Ortega-Paz L, Franchi F, Rollini F, Galli M, Been L, Ghanem G, Shalhoub A, Ossi T, Rivas A, Zhou X, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Jennings LK, Angiolillo DJ. Ortega-Paz L, et al. Thromb Haemost. 2024 Mar;124(3):263-273. doi: 10.1055/a-2098-6639. Epub 2023 May 24. Thromb Haemost. 2024. PMID: 37224883 Clinical Trial.
118 results